ArticleOncology letters2016
Gastric tube reconstruction prevents postoperative recurrence and metastasis of esophageal cancer.
Article in Oncology letters, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
8 citing papers in PubMed, 1 synthesis or guideline pooled it, 10 citations in OpenAlex.
- Gastric-tube versus whole-stomach esophagectomy for esophageal cancer: A systematic review and meta-analysis.PloS one · 2017Pooled it
- Clinical observation of modified gastric tube in middle and lower thoracic esophageal carcinoma surgery.Journal of cardiothoracic surgery · 2019Trial
- Dietary habits and nutrition status in esophageal cancer patients after esophageal reconstruction.Journal of thoracic disease · 2024Article
- Comparison of the subtotal and narrow gastric conduit for cervical esophagogastrostomy after esophagectomy in esophageal cancer patients: a propensity score-matched analysis.Esophagus : official journal of the Japan Esophageal Society · 2024Article
- Different gastric tubes in esophageal reconstruction during esophagectomy.Esophagus : official journal of the Japan Esophageal Society · 2023Review
- Impact of Reconstruction Route on Postoperative Morbidity After Esophagectomy: Analysis of Esophagectomies in the Japanese National Clinical Database.Annals of gastroenterological surgery · 2022Article
- A new technology for reducing anastomotic fistula in the neck after esophageal cancer surgery.Journal of thoracic disease · 2019Article
- Comparison of the outcomes between thoracoscopic and laparoscopic esophagectomy via retrosternal and prevertebral lifting paths by the same surgeon.World journal of surgical oncology · 2017Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Esophagectomy is the main method of treating patients with esophageal cancer. Tubular stomach and whole stomach approaches may be used for esophagectomy. However, it is not known to what extent these surgical methods are associated with postoperative recurrence and metastasis. Therefore, we aimed to investigate the effect of the tubular and whole stomach approaches on postoperative recurrence and metastasis in esophageal cancer patients. One hundred and twenty-one patients that were diagnosed with esophageal cancer by gastroscopic biopsy between March 2010 and March 2011 in Taian Central Hospital, China, were recruited into this study. There were 67 cases in the gastric tube group and 54 cases in whole stomach group. All of the patients underwent esophagectomy and there were no mortalities during surgery. All patients completed the follow-up period. The rates of recurrence or metastasis 1 and 2 years after surgery in the gastric tube group were observed to be lower than those in the whole stomach group. The two-year survival rates of the gastric tube group and whole stomach group were 80 and 61%, respectively. There was a significant difference in the survival rate between the two groups (P=0.016). In conclusion, this study suggests that esophageal cancer patients may gain a mid-term benefit from gastric tube reconstruction.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.